Skip to main content
. 2021 May 14;10(11):3635–3645. doi: 10.1002/cam4.3921

FIGURE 2.

FIGURE 2

Molecular recurrence‐free survival after TKI cessation according to eligibility criteria proposed in Hughes et al., 6 Rea et al., 7 Radich et al., 8 and Hochhaus et al., 9 (N = 95 pts)